VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Viatris Inc publishes a filing, an earnings call transcript or a press release.
Get VTRS alertsSanjeev Narula is recorded as CFO at Viatris Inc (VTRS). The proxy statement of Viatris Inc reports total compensation of $5,249,151 for Sanjeev Narula in fiscal 2024, including a base salary of $185,000. Disclosed compensation is on record for 5 fiscal years. Sanjeev Narula has spoken on 8 earnings calls across 1 company, most recently for Viatris Inc on November 7, 2023. Viatris Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Viatris Inc includes Scott A. Smith (CEO and Board Member), Robert J. Coury (Chairman and Board Member), Theodora (Doretta) Mistras (CFO) and 7 others.
“Before I begin, I would also like to extend my congratulations to Rajiv. It has been a great partnership over the past three years, and I am proud of what we've accomplished together.”
“We had another excellent quarter and are seeing the results of our efforts, which include revenue growth versus the prior year. Unless otherwise stated, I will be making year-on-year comparisons on a divestiture-adjusted operational basis as defined in our earnings release.”
“We're off to a great start to the year and as a team could not be more confident in our strategy to deliver our plan and return the company to growth. As Scott mentioned, the first quarter was in line or slightly ahead of our expectations.”
“Let me start with what you heard from Robert, in particular as it relates to 2024. We continue to feel confident about the starting point for Phase II as communicated in November of last year, and nothing has changed from then to now.”
“It's great to be with you today to share my reflections on the recent quarter and elaborate on what you've heard from Robert, Michael, and Rajiv about our company's outlook.”
VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Viatris Inc (VTRS) | Former Chief Financial Officer | $185,000 | $5,249,151 |
| 2023 | Viatris Inc (VTRS) | Former Chief Financial Officer | $923,558 | $6,780,242 |
| 2022 | Viatris Inc (VTRS) | Former Chief Financial Officer | $840,385 | $6,108,406 |
| 2021 | Viatris Inc (VTRS) | Former Chief Financial Officer | $800,000 | $5,650,685 |
| 2020 | Viatris Inc (VTRS) | Chief Financial Officer | $539,183 | $2,928,923 |